---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000117"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:27:05.356584+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Globus Medical expands share repurchase program by $200M; total capacity over $295M

## Summary
- Board authorized additional $200M for share repurchases, supplementing ~$95.3M remaining from prior program.
- Total available repurchase capacity now exceeds $295M; program has no time limit.
- Management retains discretion on timing and amount, based on market conditions and legal requirements.
- Funding from cash reserves; company balances capital allocation between growth investments and shareholder returns.
- Executive Chairman David Paul cited confidence in long-term growth and earnings strength.

## SEC filing metadata
- accession: 0001562762-22-000117
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000117/0001562762-22-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000117/gmed-20220304x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000117
- JSON: https://secwatch.observer/filing/0001562762-22-000117.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.